TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.110
+0.020 (1.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
TherapeuticsMD Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 5.05 | 4.33 | 38.07 | 64.91 | 80.49 | 160.83 | Upgrade
|
| Cash & Short-Term Investments | 5.05 | 4.33 | 38.07 | 64.91 | 80.49 | 160.83 | Upgrade
|
| Cash Growth | -50.35% | -88.63% | -41.35% | -19.36% | -49.96% | -0.48% | Upgrade
|
| Receivables | 3.32 | 3.09 | - | - | 32.38 | 24.4 | Upgrade
|
| Inventory | - | - | - | - | 7.99 | 11.86 | Upgrade
|
| Prepaid Expenses | 0.16 | 0.25 | 1.17 | 2.73 | 2.57 | 10.78 | Upgrade
|
| Restricted Cash | - | - | 11.25 | - | - | - | Upgrade
|
| Other Current Assets | 3.62 | 4.13 | 4.87 | 51.83 | 4.98 | 0.55 | Upgrade
|
| Total Current Assets | 12.15 | 11.8 | 55.35 | 119.47 | 128.4 | 208.42 | Upgrade
|
| Property, Plant & Equipment | 6.3 | 6.87 | 7.66 | 9.06 | 11.51 | 12.62 | Upgrade
|
| Other Intangible Assets | 4.43 | 6.1 | 6.94 | 7.14 | 41.45 | 44.48 | Upgrade
|
| Long-Term Accounts Receivable | 16.61 | 18.48 | 20.25 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.06 | 0.25 | 33.8 | 0.25 | 0.47 | Upgrade
|
| Total Assets | 39.55 | 43.31 | 90.46 | 169.47 | 181.61 | 265.99 | Upgrade
|
| Accounts Payable | 0.23 | 0.03 | 2.16 | 3.37 | 21.07 | 19.18 | Upgrade
|
| Accrued Expenses | 1.2 | 1.66 | 12.76 | 9.12 | 28.86 | 32.32 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 188.27 | - | - | Upgrade
|
| Current Portion of Leases | 1.62 | 1.47 | 1.39 | 1.36 | 2.25 | 1.5 | Upgrade
|
| Other Current Liabilities | 2.92 | 3.69 | 30.53 | 50.77 | 7.06 | - | Upgrade
|
| Total Current Liabilities | 5.98 | 6.85 | 46.84 | 252.89 | 59.24 | 53 | Upgrade
|
| Long-Term Debt | - | - | - | - | 237.7 | 194.63 | Upgrade
|
| Long-Term Leases | 5.78 | 6.53 | 7.37 | 8.06 | 8.68 | 9.15 | Upgrade
|
| Other Long-Term Liabilities | 0.71 | 0.64 | 1.11 | 2.14 | - | - | Upgrade
|
| Total Liabilities | 12.46 | 14.02 | 55.32 | 263.09 | 305.61 | 256.78 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.3 | 0.27 | Upgrade
|
| Additional Paid-In Capital | 979.16 | 978.92 | 974.5 | 957.73 | 754.64 | 704.35 | Upgrade
|
| Retained Earnings | -952.07 | -949.64 | -939.36 | -1,051 | -878.95 | -695.42 | Upgrade
|
| Shareholders' Equity | 27.09 | 29.29 | 35.14 | -93.62 | -124 | 9.2 | Upgrade
|
| Total Liabilities & Equity | 39.55 | 43.31 | 90.46 | 169.47 | 181.61 | 265.99 | Upgrade
|
| Total Debt | 7.4 | 8.01 | 8.76 | 197.69 | 248.63 | 205.28 | Upgrade
|
| Net Cash (Debt) | -2.35 | -3.68 | 29.31 | -132.79 | -168.14 | -44.45 | Upgrade
|
| Net Cash Per Share | -0.21 | -0.35 | 3.13 | -16.68 | -30.50 | -9.02 | Upgrade
|
| Filing Date Shares Outstanding | 11.53 | 11.53 | 9.95 | 8.67 | 7.76 | 5.43 | Upgrade
|
| Total Common Shares Outstanding | 11.53 | 11.53 | 9.5 | 8.6 | 6 | 5.42 | Upgrade
|
| Working Capital | 6.18 | 4.94 | 8.51 | -133.42 | 69.17 | 155.41 | Upgrade
|
| Book Value Per Share | 2.35 | 2.54 | 3.70 | -10.89 | -20.68 | 1.70 | Upgrade
|
| Tangible Book Value | 22.67 | 23.19 | 28.2 | -100.77 | -165.45 | -35.28 | Upgrade
|
| Tangible Book Value Per Share | 1.97 | 2.01 | 2.97 | -11.72 | -27.60 | -6.50 | Upgrade
|
| Machinery | - | 2.1 | 2.1 | 2.34 | 3.19 | 3.11 | Upgrade
|
| Leasehold Improvements | - | 0.05 | 0.05 | 0.08 | 0.08 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.